Clinical Trial

JSKN033 in Chinese Subjects with Advanced Malignant Tumors

Name: JSKN033 in Chinese Subjects with Advanced Malignant Tumors — clinical trial record (NCT06770881)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a phase I/II multicenter study to evaluate the safety and efficacy of JSKN033 in Chinese subjects with unresectable locally advanced/metastatic solid tumors.

Trial Details

NCT Number	NCT06770881
Lead Sponsor	Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Conditions	Advanced Malignant Tumors
Enrollment	430 participants
Start Date	2025-01-15
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-01-13